DEEP RESEARCH · INBODY
InBody Share Buyback Trust Agreement Disclosure Note
A short disclosure review of the KRW 5 billion treasury-share trust agreement and shareholder-value signal
0. Bottom line first
InBody disclosed a treasury-share acquisition trust agreement worth KRW 5 billion. The amount equals 1.59% of the KRW 310.6 billion market capitalization shown in the original note, and the stated purpose is share-price stabilization and shareholder-value enhancement. I was glad to see this because it feels like the first buyback/cancellation-style disclosure I have noticed from the company.
1. Key disclosure numbers
Official fact: The company is InBody, and the original note lists its market capitalization as KRW 310.6 billion. The report title is a material disclosure on the decision to enter into a treasury-share acquisition trust agreement.
| Item | Detail |
|---|---|
| Contract amount | KRW 5 billion |
| Market-cap ratio | 1.59% |
| Purpose | Share-price stabilization and shareholder-value enhancement |
| Institution | Shinhan Securities Co., Ltd. |
| Start date | 2024-08-26 |
| End date | 2025-02-25 |
2. My interpretation
Interpretation: I appreciate the company also working on shareholder value. I hope InBody continues expanding beyond body-composition analyzers into other medical-device areas. This memo is mainly to record the disclosure numbers and the fact that the company is paying attention to shareholder returns.
3. Links to check
- Disclosure link: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240826000155
- Company information: https://finance.naver.com/item/main.nhn?code=041830
Sources
- Naver Blog original: https://m.blog.naver.com/PostView.naver?blogId=star_of_self&logNo=223561204907
- DART disclosure: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240826000155
- Naver Finance company page: https://finance.naver.com/item/main.nhn?code=041830